Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fenway Partners is a U.S.-based middle-market private equity investment firm, not a biotechnology, pharmaceutical, or healthcare operating company. The firm invests in U.S. businesses with established market positions and a history of profitable operations, typically in the middle market. Public descriptions of the firm emphasize sectors such as consumer branded products, transportation, logistics, manufacturing, and specialty distribution rather than drug discovery or medical product development. While it may invest in companies that touch healthcare services from time to time, Fenway Partners itself does not appear to develop therapeutics, run a biotech pipeline, or operate as a life sciences platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fenway Partners.